Specifically, in obese female mice, SMC-MR deletion prevented the decline in coronary endothelium-dependent vasodilation and increase of vasoconstriction as well as impaired cardiac diastolic function, but not cardiac hypertrophy. The gene discussed is NR3C2; the disease is cardiac hypertrophy.